CDNA.US CareDx Inc

Healthcare Biotechnology USA Stocks
77.88 USD
Close of Nov 14, 2026
15.15 90.87
Market cap
USD 4.09B
P/E
33.6x
P/B
8.96x
ROE
37.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CDNA.US undervalued?

Graham number

The Graham number of CareDx Inc cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CareDx Inc fundamental analysis

No fundamental analysis for CareDx Inc yet.

CareDx Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CareDx Inc

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant pa…

Full company profile